Moreover, the regression analysis found that increased admission levels of MMP-9 were associated with an elevated risk of hemorrhagic transformation (HT) and predicted worse neurological outcomes at discharge and during the 3-month follow-up period. Here, MMP9 is linked to hematocrit.